Biotechnology
News Category
Antibody Therapeutics Sector Deal Activity Highlights Value for VERAXA Biotech (VRXA) Shareholders
The article discusses how strategic licensing agreements and acquisitions in antibody therapeutics, particularly ADCs and T-cell engagers, create earl...
Quantum BioPharma CEO Discusses Lucid-MS Strategy and unbuzzd Progress on BioMedWire Podcast
Quantum BioPharma executive co-chair Anthony Durkacz detailed the company's multiple sclerosis drug candidate Lucid-MS and its alcohol metabolism acce...
MindBio Therapeutics Delivers First Edge AI Intoxication Detection Kiosk Prototypes
MindBio Therapeutics has completed and delivered its first prototype Edge AI Intoxication and Fatigue Detection Kiosks, marking a significant step tow...
Quantum BioPharma Details MS Drug Candidate and Growth Strategy in Executive Podcast
Quantum BioPharma's executive co-chairman Anthony Durkacz discussed the company's lead multiple sclerosis drug candidate Lucid-MS and its alcohol meta...
VERAXA Biotech AG’s Antibody Platform Positioned for Value Creation Amid Strong Sector Deal Activity
The article highlights how VERAXA Biotech AG, with its next-generation antibody platform, is poised to benefit from the sustained high level of strate...
Onco-Innovations Secures CAD$5 Million Private Placement to Advance Cancer Programs
Onco-Innovations Limited announced a term sheet for a CAD$5 million private placement with institutional investors, with proceeds earmarked for develo...
Onco-Innovations Advances ONC010 Manufacturing Development With Nanosoft
Onco-Innovations Limited announced the initiation of polymer process development and analytical characterization by Nanosoft Polymers to support the s...
Annovis Bio Promotes Cheng Fang to Chief Scientific Officer as Phase 3 Alzheimer's Study Nears Data
Annovis Bio promoted Cheng Fang to chief scientific officer to lead scientific strategy as the company advances buntanetap toward Phase 3 Alzheimer's ...
GeoVax Highlights U.S. Government Investment in Orthopox Preparedness as Validation of Long-Term Vaccine Readiness
GeoVax comments on recent U.S. government procurement of ACAM2000 smallpox vaccine, reinforcing the strategic importance of sustained investment in or...
Active Hybrid Humidification Incubator Market to Reach USD 229.2 Million by 2036 Amid Rising Demand for Advanced Cell Culture Systems
The active hybrid humidification incubator market is projected to grow from USD 90.0 million in 2026 to USD 229.2 million by 2036 at a CAGR of 9.8%, d...
Helix BioPharma Appoints General Counsel and VP of Clinical Operations Ahead of U.S. Listing
Helix BioPharma strengthens its executive team with Helen Middleton as General Counsel and David Browning as VP of Clinical Operations to support its ...
HeartBeam Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
HeartBeam (NASDAQ: BEAT) has completed patient enrollment early in its ALIGN-ACS pilot study for heart attack detection using its 3D ECG technology, w...
Cardio Diagnostics Holdings Leverages Epigenetics to Reveal Hidden Heart Disease Risks
Cardio Diagnostics Holdings uses epigenetics to assess cardiovascular risk beyond DNA, highlighting how lifestyle and environment impact gene expressi...
Onco-Innovations Advances Manufacturing and Development of PNKP Inhibitors for Hard-to-Treat Cancers
Onco-Innovations Ltd. is advancing kilogram-scale production of its lead PNKP inhibitor ONC010 and partnering with Nanosoft Polymers to optimize drug ...
TechForce Robotics Expands RaaS Platform into Laboratory Automation with Oncotelic Therapeutics Deployment
TechForce Robotics has deployed its LIM-E autonomous laboratory support robot at Oncotelic Therapeutics, marking its first entry into pharmaceutical a...
Silo Pharma Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
Silo Pharma announced a robustness study for its SPC-15 intranasal PTSD treatment delivery system, supporting regulatory progress toward a Type C meet...
Creative Biolabs Expands Custom Oligosaccharide Synthesis and Glycan Characterization to Accelerate Drug Discovery
Creative Biolabs integrates advanced synthesis and analytical platforms to provide structurally validated oligosaccharides, reducing technical risks a...
Creative Enzymes Launches AI-Integrated Biocatalysis Platform to Accelerate Enzyme Development
Creative Enzymes' new AI-driven platform reduces enzyme development time from 12-24 months to 8-12 months by combining computational enzyme engineerin...
Amerigo Scientific Launches High-Purity iPSC-Derived Cells to Accelerate Biomedical Research and Cell Therapy Development
Amerigo Scientific releases premium iPSC-derived cells and engineered reporter lines, providing robust tools for disease modeling, drug screening, and...
Quantum BioPharma Hits Midpoint Milestone in MS Imaging Study, Early Results Show Promise
Quantum BioPharma announced that its collaborative multiple sclerosis imaging study with Massachusetts General Hospital has reached the halfway point ...
Cardio Diagnostics Leverages Epigenetics to Uncover Hidden Heart Disease Risks
Cardio Diagnostics Holdings uses epigenetics to assess cardiovascular risk beyond genetics, highlighting how lifestyle and environment influence gene ...
SUIC and VisionRenu Sign Strategic MOU to Accelerate AI Biotechnology and U.S. Capital Market Expansion
SUIC Worldwide Holdings Ltd. and VisionRenu Biomedical Technology Co., Ltd. have signed a strategic MOU to collaborate on AI-powered biotechnology, pr...
Oncotelic Therapeutics Publishes Peer-Reviewed Validation of Deciparticle Platform, Advancing Intravenous Delivery of Poorly Soluble Drugs
Oncotelic Therapeutics announced the publication of a peer-reviewed manuscript validating its Deciparticle nanoparticle platform, which enables intrav...
Tonix Pharmaceuticals Enrolls First Patient in Phase 2 Depression Trial, Targeting Unmet Need in MDD
Tonix Pharmaceuticals has enrolled the first patient in its HORIZON Phase 2 trial evaluating TNX-102 SL as a first-line monotherapy for major depressi...
Xlife Sciences Shareholders Approve All Proposals at Annual General Meeting, Highlight Key Milestones
Xlife Sciences AG shareholders approved all proposals at the AGM, with the company emphasizing the Nasdaq listing of Veraxa Biotech and the planned La...
Stonegate Capital Partners Initiates Coverage on OS Therapies Inc. (NYSE: OSTX)
Stonegate Capital Partners initiates coverage on OS Therapies, highlighting its lead therapy OST-HER2 for osteosarcoma, regulatory progress toward Acc...
Onassis Holdings Launches Regulation A+ Financing with Dalmore Group to Raise Up to $75 Million Annually
Onassis Holdings (OTC: ONSS) announced a Regulation A+ financing round with Dalmore Group, enabling the biotech holding company to raise up to $75 mil...
Oncotelic Therapeutics Highlighted in NetworkNewsWire Editorial on Innovative Therapeutics Pipeline
Oncotelic Therapeutics is featured in a NetworkNewsWire editorial for its leadership in RNA-based, immunotherapy, and targeted therapeutics, addressin...
New Smart Pen Detects Parkinson's Disease with 96% Accuracy in Early Stages
UCLA researchers have developed a smart pen that detects early-stage Parkinson's disease with 96.22% accuracy, potentially enabling earlier treatment ...
Clene’s CNM-Au8 Shows Preclinical Promise in Restoring Cellular Health in Parkinson’s Disease
Clene Inc. presented new preclinical data for CNM-Au8, demonstrating improvements in mitochondrial health and metabolism in Parkinson’s disease models...
Oncotelic Therapeutics Advances Cancer Research with AI and Nanomedicine, Offering New Hope for Hard-to-Treat Cancers
Oncotelic Therapeutics leverages AI, nanomedicine, and a robust IP portfolio to develop innovative treatments for glioblastoma, pancreatic cancer, and...
GeoVax to Showcase CM04S1 COVID-19 Vaccine Data at Emerging Growth Conference
GeoVax will present interim clinical data for its next-generation COVID-19 vaccine CM04S1, showing superior immune responses in immunocompromised pati...
Kairos Pharma Reports Positive Interim Phase 2 Data for ENV105 in Prostate Cancer
Kairos Pharma announced that its Phase 2 trial of ENV105 combined with apalutamide in metastatic castration-resistant prostate cancer achieved median ...
Creative Biolabs Expands IVD Capabilities with Integrated Protein and Nucleic Acid Detection
Creative Biolabs advances in vitro diagnostics by offering combined protein and nucleic acid detection services, enhancing early disease detection and...
Creative Biolabs Accelerates CAR-T Therapy Research with Advanced Platforms and Off-the-Shelf Plasmids
Creative Biolabs is driving CAR-T therapy innovation by providing a one-stop development platform, including GMP-like and ready-made viral vectors, to...
ABVC BioPharma Reports US$1.03 Million in Licensing Revenues in Q3, Highlighting High-Margin Model
ABVC BioPharma has collected US$1.03 million in licensing revenues from partners in Q3 2025, demonstrating a high-margin business model with minimal o...
Lexaria’s DehydraTECH Boosts Semaglutide Levels in Brain, Potentially Enhancing GLP-1 Drug Safety and Efficacy
Lexaria Bioscience reports that its DehydraTECH technology increases semaglutide brain biodistribution in rats, which may improve safety and efficacy ...
Insilico Medicine CEO Alex Zhavoronkov Discusses the Path to Pharmaceutical Superintelligence
Alex Zhavoronkov, CEO of Insilico Medicine, outlines the vision for Pharmaceutical Superintelligence, a fully autonomous AI platform for drug discover...
Oncotelic Therapeutics Highlighted in NetworkNewsAudio for Innovative Drug Pipeline and CEO's Track Record
Oncotelic Therapeutics is featured in a NetworkNewsAudio release emphasizing its innovative therapeutics pipeline and the leadership of CEO Dr. Vuong ...
Nutriband Secures FDA Type C Meeting for AVERSA Fentanyl Patch, Paving Clear Regulatory Path
Nutriband's FDA Type C meeting approval for AVERSA Fentanyl signals agency recognition and provides a clear development pathway through the 505(b)(2) ...
Oncotelic Therapeutics Advances Late-Stage Pipeline Under Proven Leadership
Oncotelic Therapeutics, led by Dr. Vuong Trieu, inventor of Abraxane and Cynviloq, is progressing its Phase 3 OT-101 for pancreatic cancer and other h...
Soligenix Advances SGX942 for Oral Mucositis with Positive Clinical Data Guiding Pivotal Trial Design
Soligenix is analyzing combined Phase 2 and 3 data to design a pivotal Phase 3 trial for SGX942, a first-in-class therapeutic targeting severe oral mu...
GeoVax Reaffirms Commitment to Evidence-Based Vaccine Safety as GEO-CM04S1 Advances for Vulnerable Populations
GeoVax Labs underscores its dedication to rigorous safety monitoring and transparent science, highlighting the potential of its investigational COVID-...
BB Biotech Joins SPI ESG Index, Reinforcing Commitment to Sustainable Investing
BB Biotech AG has been included in the SPI ESG Index of the SIX Swiss Exchange as of September 22, 2025, highlighting its dedication to responsible in...
Fifty 1 Labs Engages PCAOB Auditor for Planned OTCQB Uplist
Fifty 1 Labs announces engagement of a PCAOB-registered auditor for 2024 and 2025 financial audits, a critical step toward an OTCQB uplist aimed at en...
Creative Biolabs Launches Antibody Tools for Neuroscience Research
Creative Biolabs introduces new antibody products targeting GRID2, tyrosine hydroxylase, and ACTN3 to support research in synaptic function, neurotran...
Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent
Quantumzyme Corp.'s patent for an enzymatic ibuprofen synthesis process marks a key step toward greener pharmaceutical manufacturing, enabling licensi...
GeoVax Expands Gedeptin Development to Additional Solid Tumor Indications
GeoVax is expanding its Gedeptin gene therapy to treat additional solid tumors beyond head and neck cancer, leveraging checkpoint inhibitor synergy an...